| Literature DB >> 33318716 |
Patricia Baudier1, Galina Kondrateva2, Chantal Ammi3, Victor Chang4, Francesco Schiavone5.
Abstract
In recent months, humanity has had to deal with a worldwide pandemic called COVID-19, which has caused the death of hundreds of thousands of people and paralyzed the global economy. Struggling to cure infected patients while continuing to care for patients with other pathologies, health authorities have faced the lack of medical staff and infrastructure. This study aimed to investigate the acceptance of teleconsultation solutions by patients, which help to avoid the spread of the disease during this pandemic period. The model was built using some constructs of the technology acceptance model UTAUT2, Personal traits, Availability, and Perceived Risks. A new scale on Contamination Avoidance was developed by the authors. The questionnaire was disseminated in several countries in Europe and Asia and a total sample of 386 respondents was collected. The results emphasize the huge impact of Performance Expectancy, the negative influence of Perceived Risk, and the positive influence of Contamination Avoidance on the adoption of teleconsultation solutions. The findings highlight the moderating effects of Age, Gender, and Country.Entities:
Keywords: Acceptance; COVID-19; Pandemic; Teleconsultation; Telemedicine
Year: 2020 PMID: 33318716 PMCID: PMC7720768 DOI: 10.1016/j.techfore.2020.120510
Source DB: PubMed Journal: Technol Forecast Soc Change ISSN: 0040-1625
Fig. 1Research model.
Test sample characteristics.
| Female | 58 |
| Male | 29 |
| 21–25 | 28 |
| 26–35 | 17 |
| 36–45 | 23 |
| Above 45 | 19 |
Final sample characteristics.
| % | ||
| Female | 214 | 55% |
| Male | 172 | 45% |
| China | 57 | 15% |
| France | 107 | 28% |
| Italy | 82 | 21% |
| UK | 67 | 17% |
| Others | 73 | 19% |
| 18–25 | 63 | 16% |
| 26–35 | 118 | 31% |
| 36–55 | 129 | 33% |
| >55 | 76 | 20% |
Test of hypotheses (X=Supported, ONot Supported).
| 0.375 | 0.291 | |||||||
| Self-Efficacy | 0.215 | 0.423 | 6.611 | 0.000 | X | |||
| Personal Innovativeness | 0.093 | 0.279 | 4.723 | 0.000 | X | |||
| 0.693 | 0.556 | |||||||
| Effort Expectancy | 0.009 | 0.080 | 1.473 | 0.141 | O | |||
| Habit | 0.018 | 0.119 | 2.472 | 0.013 | X | |||
| Performance Expectancy | 0.544 | 0.634 | 12.616 | 0.000 | X | |||
| Perceived Risk | 0.012 | (−0.067) | 2.339 | 0.019 | X | |||
| Social Influence | 0.001 | (−0.022) | 0.709 | 0.478 | O | |||
| 0.449 | 0.330 | |||||||
| Availability | 0.521 | 0.577 | 13.487 | 0.000 | X | |||
| Contamination Avoidance | 0.055 | 0.188 | 3.839 | 0.000 | X | |||
Age as a moderator.
| 0.349 | 2.852 | 0.004 | 0.132 | 1.303 | 0.193 | 0.252 | 2.871 | 0.004 | 0.135 | 1.624 | 0.104 | |
| 0.175 | 1.271 | 0.204 | (−0.001) | 0.006 | 0.994 | 0.139 | 1.495 | 0.135 | 0.262 | 3.068 | 0.002 | |
| 0.131 | 0.948 | 0.343 | 0.263 | 2.705 | 0.007 | 0.353 | 3.620 | 0.000 | 0.293 | 2.214 | 0.027 | |
| (−0.204) | 2.337 | 0.019 | (−0.044) | 0.517 | 0.604 | 0.034 | 0.710 | 0.477 | (−0.090) | 1.448 | 0.148 | |
Country as a moderator.
| 0.232 | 1.616 | 0.106 | 0.147 | 2.003 | 0.045 | 0.214 | 1.570 | 0.116 | 0.373 | 3.664 | 0.000 | |
| 0.276 | 1.646 | 0.099 | 0.190 | 2.277 | 0.022 | (−0.016) | 0.191 | 0.848 | 0.222 | 1.635 | 0.102 | |
| 0.073 | 0.438 | 0.661 | 0.170 | 1.587 | 0.112 | 0.233 | 2.311 | 0.020 | 0.133 | 1.181 | 0.237 | |
| (−0.044) | 0.380 | 0.703 | (−0.112) | 2.074 | 0.038 | (−0.134) | 1.381 | 0.167 | (−0.099) | 0.941 | 0.346 | |
| 0.214 | 1.547 | 0.121 | 0.018 | 0.339 | 0.734 | 0.160 | 2.032 | 0.042 | 0.062 | 0.839 | 0.401 | |
Gender as a moderator.
| 0.168 | 2.514 | 0.011 | 0.050 | 0.724 | 0.468 | |
| (−0.143) | 3.373 | 0.000 | 0.022 | 0.550 | 0.582 | |
| Expert1 | University of Naples Parthenope | Italy | Associate Professor | Management | 13 |
| Expert2 | College of Business and Economics, West Virginia | USA | Associate Professor | Finance | 16 |
| Expert3 | University of Stuttgart | Germany | Full Professor | Management of Innovation | 12 |
| Expert4 | University of Nantes | France | Full Professor | Management of Innovation | 30 |
| Expert5 | Teesside University | UK | Full Professor | Data Science and IS | 20 |
| Expert6 | Catholic University of Louvain | Belgium | Associate Professor | Management of Innovation | 7 |
| Expert7 | Business School, Beijing Normal University | China | Associate Professor | Management of Innovation | 12 |
| Expert8 | Peter The Great St Petersburg Polytechnic University | Russia | Associate Professor | Management of Innovation | 26 |
| Expert9 | Pardis Ltd | Austria | PhD; MD | Management of Innovation | 32 |
| Expert10 | ISC Paris Business School | France | Associate Professor | Finance | 10 |
| Expert11 | University and IAE of Bordeaux | France | Full Professor | Marketing | 35 |
| Expert12 | EDC Business School | France | Full Professor | Marketing | 46 |
| Expert13 | EMLV Business School | France | Associate Professor | Digital Marketing | 6 |
| [ITU1.You think it is a good idea to use teleconsultation] |
| [ITU2.You will always use teleconsultation in the near future to access healthcare professionals] |
| [ITU3.You plan to use teleconsultation] |
| [PE1.Using a teleconsultation would be useful] |
| [PE2.Teleconsultation would allow you to access healthcare faster] |
| [PE3.Using teleconsultation would increase your productivity] |
| [PE4.Teleconsultation would increase your chances of achieving healthcare] |
| [EE1.Learning how to use teleconsultation is easy for you] |
| [EE2.Your interaction with teleconsultation is clear and understandable] |
| [EE3.You find teleconsultation easy to use] |
| [EE4.It is easy for you to become skillful at using teleconsultation] |
| [SI1.People who are important to you think that you should use it] |
| [SI2.Your environment (family, friends) influences your intention to use it] |
| [SI3.This gives you higher status than those who do not use teleconsultation] |
| [SI4.Healthcare staff encourage the use of teleconsultation] |
| [FC1.You have IT knowledge to use this solution] |
| [FC2.You can get help around in case of difficulties] |
| [FC3.Teleconsultation is compatible with other technologies you use] |
| [FC4.You have the necessary training to use this solution] |
| [HA1.Using teleconsultation could become a habit for you] |
| [HA2.You could become “addicted” to the use of teleconsultation] |
| [HA3.You could use teleconsultation often] |
| [HA4.Using teleconsultation could become natural to you] |
| [PR1.The use of teleconsultation would result in a loss of confidentiality, because the information could be used without your knowledge] |
| [PR2.Using a teleconsultation would not correspond to your personal values or your self-image] |
| [PR3.To learn how to use and adapt teleconsultation would be a significant waste of time] |
| [PR4.The use of teleconsultation would cause risks for the treatment and diagnosis of patients] |
| [PI1.You like to experiment with technological innovations] |
| [PI2.If you hear about a new technology, you want to try it] |
| [PI3.In your entourage, you are usually the first to try new technology] |
| [SE1.use teleconsultation if you can call someone in case of problems] |
| [SE2.deal with most of the problems you might encounter while using teleconsultation] |
| [SE3.stay calm when you face difficulties in teleconsultation use because you can count on your skills] |
| [AV1.You can get the care you need on time] |
| [AV2.You can consult when you are available] |
| [AV3.Teleconsultation will always be available when you need it] |
| [CA1.On the way to your doctor's office] |
| [CA2.In the waiting room in contact with other patients] |
| [CA3.In contact with your doctor] |
| [CA4.By touching contaminated objects (door handles, chairs, etc.)] |